Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 step » _ step (Expand Search), a step (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 step » _ step (Expand Search), a step (Expand Search)
-
12141
Data Sheet 1_Global, regional, and national burdens of pancreatitis in children and adolescents aged 0–24 years from 1992 to 2021: a trend analysis based on the global burden of di...
Published 2025“…Background<p>The younger onset of pancreatitis presents a significant public health challenge. This study aims to analyze the global burden of pancreatitis in younger populations based on the Global Burden of Disease 2021.…”
-
12142
Pros and cons of insulin administration on liver glucose metabolism in strength-trained healthy mice
Published 2019“…The trained animals increased their muscle strength (+100%) and decreased body weight gain (–11%), subcutaneous fat (–42%), mesenteric fat (–45%), and peritoneal adipocyte size (–33%) compared with the sedentary groups. …”
-
12143
Ultrathin Micellar Foam Films of Sodium Caseinate Protein Solutions
Published 2023“…Furthermore, stratifying SDS foam films show stepwise thinning, such that the step-size and terminal film thickness decrease with concentration. …”
-
12144
Ultrathin Micellar Foam Films of Sodium Caseinate Protein Solutions
Published 2023“…Furthermore, stratifying SDS foam films show stepwise thinning, such that the step-size and terminal film thickness decrease with concentration. …”
-
12145
Table 1_Time trends in mortality of congenital heart disease in children aged 0–14 years: a global, regional, and national cohort analysis from 1990 to 2021 using the global burden...
Published 2025“…</p>Methods<p>This study utilized the Global Burden of Disease (GBD) database to examine trends in CHD-related mortality among children aged 0-14 from 1990 to 2021.</p>Results<p>We report a 55.34% reduction in CHD-related deaths among children, with global mortality rates decreasing from 28.63 per 100,000 in 1990 to 11.06 per 100,000 in 2021. …”
-
12146
Image 1_Time trends in mortality of congenital heart disease in children aged 0–14 years: a global, regional, and national cohort analysis from 1990 to 2021 using the global burden...
Published 2025“…</p>Methods<p>This study utilized the Global Burden of Disease (GBD) database to examine trends in CHD-related mortality among children aged 0-14 from 1990 to 2021.</p>Results<p>We report a 55.34% reduction in CHD-related deaths among children, with global mortality rates decreasing from 28.63 per 100,000 in 1990 to 11.06 per 100,000 in 2021. …”
-
12147
Table 2_Time trends in mortality of congenital heart disease in children aged 0–14 years: a global, regional, and national cohort analysis from 1990 to 2021 using the global burden...
Published 2025“…</p>Methods<p>This study utilized the Global Burden of Disease (GBD) database to examine trends in CHD-related mortality among children aged 0-14 from 1990 to 2021.</p>Results<p>We report a 55.34% reduction in CHD-related deaths among children, with global mortality rates decreasing from 28.63 per 100,000 in 1990 to 11.06 per 100,000 in 2021. …”
-
12148
Table 4_Time trends in mortality of congenital heart disease in children aged 0–14 years: a global, regional, and national cohort analysis from 1990 to 2021 using the global burden...
Published 2025“…</p>Methods<p>This study utilized the Global Burden of Disease (GBD) database to examine trends in CHD-related mortality among children aged 0-14 from 1990 to 2021.</p>Results<p>We report a 55.34% reduction in CHD-related deaths among children, with global mortality rates decreasing from 28.63 per 100,000 in 1990 to 11.06 per 100,000 in 2021. …”
-
12149
Table 3_Time trends in mortality of congenital heart disease in children aged 0–14 years: a global, regional, and national cohort analysis from 1990 to 2021 using the global burden...
Published 2025“…</p>Methods<p>This study utilized the Global Burden of Disease (GBD) database to examine trends in CHD-related mortality among children aged 0-14 from 1990 to 2021.</p>Results<p>We report a 55.34% reduction in CHD-related deaths among children, with global mortality rates decreasing from 28.63 per 100,000 in 1990 to 11.06 per 100,000 in 2021. …”
-
12150
Image 2_Time trends in mortality of congenital heart disease in children aged 0–14 years: a global, regional, and national cohort analysis from 1990 to 2021 using the global burden...
Published 2025“…</p>Methods<p>This study utilized the Global Burden of Disease (GBD) database to examine trends in CHD-related mortality among children aged 0-14 from 1990 to 2021.</p>Results<p>We report a 55.34% reduction in CHD-related deaths among children, with global mortality rates decreasing from 28.63 per 100,000 in 1990 to 11.06 per 100,000 in 2021. …”
-
12151
Data_Sheet_1_CYP2C19 genotype and platelet aggregation test-guided dual antiplatelet therapy after off-pump coronary artery bypass grafting: A retrospective cohort study.docx
Published 2022“…According to the actual treatment they received in real-world, 382 (33.7%) of them received a traditional DAPT: aspirin 100 mg qd + clopidogrel 75 mg qd, no matter the CYP2C19 genotype and response in platelet aggregation test (PAgT). …”
-
12152
<i>In-vitro</i> characterization of early osteoprogenitor cells.
Published 2016“…ALP activity of healthy donor-derived bone marrow stromal cells (HD-BMSC) and KM105 cells was assessed by ELISA at the specified time-points during osteogenesis and corrected per number of viable cells (ALP index, API). (b) <i>RUNX2 levels gradually increase during early OB differentiation and decrease with cell maturation</i>. …”
-
12153
DataSheet_1_Weight changes from early to middle adulthood and cardiometabolic multimorbidity later in life among middle-aged and older adults: a retrospective cohort study from the...
Published 2024“…However, participants with maximum overweight had a decreased incidence of stroke (HR: 0.85, 95% CI: 0.85, 0.86), and weight loss ≥ 2.5 kg and weight gain ≥ 2.5 and <20 kg were also related to a lower risk of stroke. …”
-
12154
Metabolic profiles of the muscle and hepatopancreas of the crayfish <i>Procambarus clarkii</i> 24 h after CHH dsRNA treatment.
Published 2017“…Dotted lines indicate multiple metabolic steps are involved that are not individually specified.…”
-
12155
DataSheet1_The differential impact of a 6-versus 12-month pharmacist-led interprofessional medication adherence program on medication adherence in patients with diabetic kidney dis...
Published 2024“…</p><p>Results: EM data of 72 patients were analyzed (34 in group A and 38 in group B). Patient implementation to antidiabetics and antihypertensive drugs increased during the IMAP intervention phase and decreased progressively during the follow-up period. …”
-
12156
The effects of LM on oxygen consumption (A), mitochondrial membrane potential (MMP) (B), ROS production (C); cellular ATP level (D) and the expression of MnSOD,Trx2,Prx3,and Prx5 (...
Published 2015“…(D) LM treatment decreased cellular ATP level. Values are means ± SEM from 3 independent experiments. …”
-
12157
-
12158
Aromatic C–H σ‑Bond Activation by Ni<sup>0</sup>, Pd<sup>0</sup>, and Pt<sup>0</sup> Alkene Complexes: Concerted Oxidative Addition to Metal vs Ligand-to-Ligand H Transfer Mechanis...
Published 2017“…C–H σ-bond activation of arene (represented here by benzene) by the Ni<sup>0</sup> propene complex Ni<sup>0</sup>(IMes)(C<sub>3</sub>H<sub>6</sub>) (IMes = 1,3-dimesitylimidazol-2-ylidene), which is an important elementary step in Ni-catalyzed hydroarylation of unactivated alkene with arene, was investigated by DFT calculations. …”
-
12159
<b> </b> Energy efficiency and gas volume comparison.
Published 2025“…The energy efficiency analysis revealed that the calorific value of biogas increased from 7.552 MJ at 400°C to 12.966 MJ at 800°C in the experimental group, with net energy gain decreasing as temperature increased. The mass balance showed that, during the pyrolysis stage, 100 g of biomass resulted in 35 g of biochar, 250 mL of biogas, and 50 g of bio-oil. …”
-
12160
Model validation of kinetic parameters.
Published 2025“…The energy efficiency analysis revealed that the calorific value of biogas increased from 7.552 MJ at 400°C to 12.966 MJ at 800°C in the experimental group, with net energy gain decreasing as temperature increased. The mass balance showed that, during the pyrolysis stage, 100 g of biomass resulted in 35 g of biochar, 250 mL of biogas, and 50 g of bio-oil. …”